IRIS
BOSIA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.562
EU - Europa 1.817
NA - Nord America 1.724
SA - Sud America 512
AF - Africa 47
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.623
SG - Singapore 1.071
CN - Cina 799
IT - Italia 466
BR - Brasile 444
SE - Svezia 397
HK - Hong Kong 364
RO - Romania 267
DE - Germania 145
RU - Federazione Russa 115
VN - Vietnam 99
GB - Regno Unito 98
IN - India 72
CA - Canada 59
FI - Finlandia 57
FR - Francia 47
NL - Olanda 44
PL - Polonia 44
ES - Italia 38
TR - Turchia 35
AR - Argentina 29
IE - Irlanda 29
MX - Messico 27
AT - Austria 22
JP - Giappone 20
BD - Bangladesh 17
ZA - Sudafrica 16
CO - Colombia 13
KR - Corea 12
EG - Egitto 11
PK - Pakistan 11
AU - Australia 10
ID - Indonesia 10
EC - Ecuador 9
LT - Lituania 9
IR - Iran 6
CH - Svizzera 5
IQ - Iraq 5
MA - Marocco 5
PT - Portogallo 5
BE - Belgio 4
CL - Cile 4
IL - Israele 4
JO - Giordania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
NO - Norvegia 1
OM - Oman 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.679
Salva come PNG Salva come JPEG
Città #
Singapore 493
Hong Kong 353
Dallas 222
Ashburn 211
Shanghai 196
Beijing 150
Hefei 135
Milan 120
Princeton 102
Lawrence 101
New York 72
Munich 57
São Paulo 55
Los Angeles 49
Boardman 47
Moscow 46
Helsinki 34
Warsaw 34
Ho Chi Minh City 33
Rome 31
Dublin 30
Montreal 24
Brooklyn 23
Atlanta 22
Hanoi 22
Chennai 21
Tokyo 20
The Dalles 19
Denver 18
Pittsburgh 18
Pune 18
Seattle 18
Turku 18
Frankfurt am Main 17
London 17
Santa Clara 16
Guangzhou 15
Orem 15
Poplar 15
Stockholm 15
Ankara 14
San Francisco 14
Houston 13
Vienna 13
Council Bluffs 12
Genoa 12
Toronto 12
Boston 11
Istanbul 11
Johannesburg 11
Nuremberg 11
Amsterdam 10
Belo Horizonte 10
Rio de Janeiro 10
Chicago 9
Curitiba 9
Phoenix 9
Secaucus 9
Apodaca 8
Brasília 8
Brescia 8
Washington 8
City of London 7
Fortaleza 7
Guarulhos 7
Lentate sul Seveso 7
Manchester 7
Mexico City 7
Mumbai 7
Cairo 6
Columbus 6
Dalton 6
Dhaka 6
Ottawa 6
Turin 6
Charlotte 5
Ferrara 5
Guwahati 5
Gwangjin-gu 5
Naples 5
Ribeirão Preto 5
Santander 5
St Louis 5
Tianjin 5
Xi'an 5
Auckland 4
Bogotá 4
Bologna 4
Brisbane 4
Bắc Ninh 4
Campinas 4
Cesano Boscone 4
Chongqing 4
Concord 4
Duque de Caxias 4
Florence 4
Glasgow 4
Jiaxing 4
Pisa 4
Porto Alegre 4
Totale 3.349
Salva come PNG Salva come JPEG
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 333
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 192
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 108
Assessment of pragmatic abilities and cognitive substrates (APACS) brief remote: a novel tool for the rapid and tele-evaluation of pragmatic skills in Italian 101
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 101
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 99
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 94
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 89
The cognitive architecture of verbal humor in schizophrenia 88
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 84
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 81
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 79
Cognitive reserve profiles are associated with outcome in schizophrenia 75
Adult Consequences of Neurodevelopmental Disorders 74
Mind the past: A systematic review on psychological autopsy 73
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 72
Psychotic Disorders 71
Machine Learning and Criminal Justice: A Systematic Review of Advanced Methodology for Recidivism Risk Prediction 71
Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia 70
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 68
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 67
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 67
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 66
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 66
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 64
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 63
Cognitive remediation in schizophrenia: What happens after 10 years? 62
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 62
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 62
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 61
ADDing a piece to the puzzle of cognition in schizophrenia 61
Organic Mental Disorders and Psychiatric Issues in the Elderly 60
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 57
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 57
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 57
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 56
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 56
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 56
Dysconnection in schizophrenia: Filling the dots from old to new evidence 55
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 55
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies 54
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 54
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 54
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 54
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 53
Association study of GSK-3 beta-50T/C polymorphism with executive performances in schizophrenia 53
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 53
Non-Pharmacological Treatments 52
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 52
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 51
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 51
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 51
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive rernediation in schizophrenia 51
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 51
Biochemical targets of tamoxifen and lithium in an animal model of mania 50
Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind 50
Substance-Related Disorders 47
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 47
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 46
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 46
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 46
Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms 44
Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence 44
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 43
CYP450 genotypes: metabolism and efficacy of the antidepressant mirtazapine 42
Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances 42
Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour 42
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 42
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 41
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 41
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 40
Exploring predictors of work competence in schizophrenia: The role of theory of mind 40
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome 40
COMT Val158Met and 5-HT1A-R-1019 C/G polymorphisms: effects on the negative symptom response to clozapine 39
Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome 38
Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. 37
Pragmatic abilities across symptoms dimensions in schizophrenia 37
VALUTAZIONI DEL FUNZIONAMENTO COGNITIVO “TRASFERIBILI” ALLA PRATICA CLINICA: LA BRIEF ASSESSMENT OF COGNITION SCALE (BACS) E LA SCHIZOPHRENIA COGNITION RATING SCALE (SCORS) 37
Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: Persistence after 5years 37
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 37
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art 37
The association of autistic traits with Theory of Mind and its training efficacy in patients with schizophrenia 36
Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia 35
Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia 35
Epigenetics in schizophrenia and association with antipsychotic response to clozapine: preliminary findings 35
Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism 35
Daily Functioning in Schizophrenia: Is There Room for Anxiety? 35
Theory of mind and emotion processing training for patients with schizophrenia: Preliminary findings 34
Evaluation of the role of HTR1A C-1019G polymorphism in antidepressant efficacy: a meta-analysis 34
Exploring the effect of genetic variability of adducins on cognition in schizophrenia 34
The role of genetics in cognitive remediation in schizophrenia: A systematic review 34
Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence 34
Psychedelics and schizophrenia: a double-edged sword 34
Effect of 5-HT1a and catechol-O-methyltransferase gene polymorphisms on negative symptom response to clozapine 33
Self-awareness of cognitive functioning in schizophrenia: patients and their relatives 33
The Influence of Premorbid Adjustment and Autistic Traits on Social Cognitive Dysfunction in Schizophrenia 33
Stability and Generalization of Combined Theory of Mind and Cognitive Remediation Interventions in Schizophrenia: Follow-Up Results 33
COMMUNICATION IN SCHIZOPHRENIA, BETWEEN PRAGMATICS, COGNITION AND SOCIAL COGNITION 32
Theory of mind and stereotypic behavior promote daily functioning in patients with schizophrenia 32
Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia 31
Totale 5.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 8 3 0 0 0 0 0
2021/202284 0 0 0 20 8 4 2 6 12 6 13 13
2022/2023792 240 133 58 7 47 110 34 52 50 15 23 23
2023/2024579 36 37 72 63 62 82 12 51 2 25 29 108
2024/20252.539 272 55 70 125 95 190 497 166 388 272 202 207
2025/20262.785 550 463 271 829 638 34 0 0 0 0 0 0
Totale 6.824